+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
From
From
From
Epidermolysis Bullosa - Pipeline Review, H2 2020 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 170 Pages
  • Global
From
Bullous Pemphigoid - Pipeline Review, H1 2020 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 139 Pages
  • Global
From
Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 1197 Pages
  • Global
From
From
From
From
United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more